Five-year outcomes after revascularization of superficial femoral artery occlusion using Ocelot catheter.

optical coherence tomography revascularization superficial femoral artery occlusion

Journal

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology
ISSN: 1734-9338
Titre abrégé: Postepy Kardiol Interwencyjnej
Pays: Poland
ID NLM: 101272671

Informations de publication

Date de publication:
2019
Historique:
received: 09 03 2019
accepted: 14 07 2019
entrez: 15 1 2020
pubmed: 15 1 2020
medline: 15 1 2020
Statut: ppublish

Résumé

The population of patients with lower limb atherosclerosis includes a considerable proportion of individuals with long superficial femoral artery (SFA) lesions. Chronic total occlusions (CTOs) represent the "last frontier" of percutaneous interventions. While open strategies are considered earlier as standard management for these lesions, the results of a number of trials indicate that endovascular management might become an effective alternative to surgery. This paper presents 5-year outcomes of a first-in-man (FIM) study (before CE mark) and the registry of OCT Guided Ocelot Catheter (Avinger) for chronic total occlusions of the superficial femoral artery. The study group comprised 10 patients with Rutherford 3 lower limb ischemia including nine men and one woman. The efficacy of the primary intervention was 90%. Angiography performed at 6 months of the procedure, according to the study protocol, revealed 3 and 1 cases of restenosis and reocclusion, respectively, repaired using PTA and open common and deep femoral artery patch plasty. Doppler ultrasound performed at 1, 2 and 5 years after the primary intervention did not reveal significant target vessel restenosis. The primary and primary-assisted patency was 89%. During a 5-year follow-up, four peripheral percutaneous interventions and one femoropopliteal bypass surgery were performed in non-target limbs. There were no cardiovascular deaths, myocardial infarction or stroke and no amputation was required. This is a first-in-man study reporting long-term follow-up after SFA CTO revascularization using the Ocelot catheter. The catheter proved to have a satisfactory safety profile and a high proportion of CTO crossings. A 5-year follow-up revealed high primary and primary-assisted patency rates.

Identifiants

pubmed: 31933664
doi: 10.5114/aic.2019.90222
pii: 38759
pmc: PMC6956451
doi:

Types de publication

Journal Article

Langues

eng

Pagination

472-476

Informations de copyright

Copyright: © 2019 Termedia Sp. z o. o.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Korean Circ J. 2018 Aug;48(8):685-691
pubmed: 30073806
Ital Heart J. 2003 Nov;4(11):819-20
pubmed: 14699715
EuroIntervention. 2014 Dec;10(8):1002-8
pubmed: 25308298
J Cardiovasc Surg (Torino). 2019 Apr;60(2):191-197
pubmed: 30665284
Cardiovasc Eng Technol. 2016 Jun;7(2):103-17
pubmed: 26831298
J Endovasc Ther. 2015 Dec;22(6):847-52
pubmed: 26420802
J Vasc Surg. 1985 May;2(3):491-8
pubmed: 3889383
J Invasive Cardiol. 2013 May;25(5):E96-100
pubmed: 23645062
Catheter Cardiovasc Interv. 2014 Jan 1;83(1):144-7
pubmed: 24030969
J Endovasc Ther. 2017 Jun;24(3):355-366
pubmed: 28393673
Semin Intervent Radiol. 2014 Dec;31(4):378-88
pubmed: 25435665
J Vasc Surg. 2012 Dec;56(6):1615-21
pubmed: 22975332
Int J Cardiol. 2013 May 25;165(3):423-9
pubmed: 22459363
Semin Intervent Radiol. 2015 Dec;32(4):370-3
pubmed: 26622099
JACC Cardiovasc Interv. 2009 Nov;2(11):1035-46
pubmed: 19926041
Cardiovasc Revasc Med. 2017 Dec;18(8):623-631
pubmed: 29102343
J Vasc Surg. 2007 Jan;45 Suppl S:S5-67
pubmed: 17223489
J Cardiovasc Surg (Torino). 2013 Aug;54(4):431-2
pubmed: 24013530
J Endovasc Ther. 2013 Dec;20(6):770-81
pubmed: 24325693

Auteurs

Przemysław Nowakowski (P)

Department of Vascular Surgery, American Heart of Poland, Chrzanow, Poland.
Katowice University of Technology, Katowice, Poland.

Piotr Buszman (P)

Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.
Center for Cardiovascular Research and Development, Katowice, Poland.

Adam Janas (A)

Center for Cardiovascular Research and Development, Katowice, Poland.

Stefan Kiesz (S)

San Antonio Endovascular and Heart Institute, San Antonio, USA.

Pawel Buszman (P)

Center for Cardiovascular Research and Development, Katowice, Poland.

Classifications MeSH